XML 75 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 19 - Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Share-based Compensation Arrangement by Share-based Payment Award Fair Value Assumptions and Methodology [Table Text Block]
  

2023

  

2022

  

2021

 
             

Dividend yield

  2.24%  2.38%  2.52%

Expected volatility

  27.20%  25.43%  25.19%

Risk free interest rate

  3.84%  1.98%  1.22%

Expected life of SARs (in years)

 

7.1

  

7.1

  

7.1

 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Year Ended December 31, 2023

 

(in thousands)

 

Stock

Appreciation

Rights

  

Restricted

Stock Awards

  

Restricted

Stock Units

  

Performance

Stock Units

  

Total

 
                     

Expense

 $492  $1,599  $519  $1,854  $4,464 

Deferred tax benefit

  (104)  (336)  (109)  (390)  (939)

Total net expense

 $388  $1,263  $410  $1,464  $3,525 
  

Year Ended December 31, 2022

 

(in thousands)

 

Stock

Appreciation

Rights

  

Restricted

Stock Awards

  

Restricted

Stock Units

  

Performance

Stock Units

  

Total

 
                     

Expense

 $376  $1,373  $332  $2,313  $4,394 

Deferred tax benefit

  (79)  (289)  (70)  (486)  (924)

Total net expense

 $297  $1,084  $262  $1,827  $3,470 
  

Year Ended December 31, 2021

 

(in thousands)

 

Stock

Appreciation

Rights

  

Restricted

Stock Awards

  

Restricted

Stock Units

  

Performance

Stock Units

  

Total

 
                     

Expense

 $352  $1,288  $312  $2,613  $4,565 

Deferred tax benefit

  (74)  (271)  (66)  (549)  (960)

Total net expense

 $278  $1,017  $246  $2,064  $3,605 
Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]

(in thousands)

Year Ended

 

Stock

Appreciation

Rights

  

Restricted

Stock Awards

  

Restricted

Stock Units

  

Performance

Stock Units

  

Total

 
                     

2024

 $307  $1,376  $3  $788  $2,474 

2025

  248   1,155      668   2,071 

2026

  190   854         1,044 

2027

  111   501         612 

2028

  12   41         53 

Total estimated expense

 $868  $3,927  $3  $1,456  $6,254 
Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]
                      

Weighted

 
          

Weighted

      

Weighted

  

average

 
          

average

  

Aggregate

  

average

  

remaining

 
      

Exercise

  

exercise

  

intrinsic

  

fair

  

contractual

 

(in thousands, except per share and years)

 

SARs

  

price

  

price

  

value(1)

  

value

  

life (in years)

 
                         

Outstanding, January 1, 2021

  593  

$15.24

-$40.00  $27.47  $7,706  $4.44   5.1 

Granted

  30  47.17-50.71   50.48   -   9.69     

Exercised

  (108)  15.24-19.37   16.40   4,239   2.85     

Forfeited

                    

Outstanding, December 31, 2021

  515  

$15.24

-$50.71  $31.16  $16,854  $5.08   5.1 
                          

Outstanding, January 1, 2022

  515  

$15.24

-$50.71  $31.16  $16,854  $5.08   5.1 

Granted

  34   47.17-74.92   55.45      12.07     

Exercised

  (114)  15.24-40.00   21.55   5,258   3.63     

Forfeited

                    

Outstanding, December 31, 2022

  435  

$19.37

-$74.92  $35.60  $12,784  $6.02   5.1 
                          

Outstanding, January 1, 2023

  435  

$19.37

-$74.92  $35.60  $12,784  $6.02   5.1 

Granted

  29  60.76-60.76   60.76      16.81     

Exercised

  (24) 19.37-19.37   19.37   681   3.58     

Forfeited

                    

Outstanding, December 31, 2023

  440  

$19.44

-$74.92  $38.11  $6,297  $6.86   4.7 
                          

Vested and exercisable

  336  

$19.44

-$74.92  $34.15  $5,851  $5.50   3.8 

Unvested

  104   36.65-74.92   50.83   446   11.22   3.4 

Outstanding, December 31, 2023

  440  

$19.44

-$74.92  $38.11  $6,297  $6.86   4.7 
                          

Vested in the current year

  52  

$35.90

-$74.92  $41.34  $531  $7.25     
Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights, Award Expiration Period [Table Text Block]

(in thousands, except per share data)

         

Expiration Year

 

SARs

Outstanding

  

SARs Vested and

Exercisable

  

Weighted Average

Exercise Price

 

2024

  3   3  $19.44 

2025

  39   39   23.02 

2026

  76   76   25.76 

2027

  40   40   40.00 

2028

  95   95   37.84 

2029

  47   37   37.06 

2030

  46   27   37.30 

2031

  31   12   50.48 

2032

  34   7   55.45 

2033

  29      60.76 
   440   336  $38.11 
Schedule of Nonvested Share Activity [Table Text Block]
      

Weighted

 
      

average cost

 

(in thousands, except per share data)

 

RSAs

  

at grant date

 
         

Unvested at January 1, 2021

  99  $36.85 

Shares awarded

  39   46.90 

Restrictions lapsed and shares vested

  (34)  35.48 

Shares forfeited

  (5)  40.81 

Unvested at December 31, 2021

  99  $41.07 
         

Unvested at January 1, 2022

  99  $41.07 

Shares awarded

  35   58.47 

Restrictions lapsed and shares vested

  (32)  40.39 

Shares forfeited

  (6)  47.49 

Unvested at December 31, 2022

  96  $47.26 
         

Unvested at January 1, 2023

  96  $47.26 

Shares awarded

  38   63.04 

Restrictions lapsed and shares vested

  (33)  43.77 

Shares forfeited

  (3)  53.38 

Unvested at December 31, 2023

  98  $54.23 
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

Grant

Year

 

Vesting

Period in

Years

  

Fair Value

  

Shares Expected

to be Awarded

 

2021

  3  $44.44   47,280 

2022

  3   48.48   30,118 

2023

  3   54.33   33,509 
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares to be Issued Upon Exercise and Remaining Shares Available for Future Issuance [Table Text Block]
  

Number of

      

Shares

 
  

shares to be

  

Weighted

  

available for

 
  

issued upon

  

average

  

future

 

Plan category (in thousands)

 

exercising/vesting

  

exercise price

  

issuance (a)

 
             

Equity compensation plans approved by security holders:

            
             

Stock Appreciation Rights

 

(b)

  

(b)

   151 

Restricted Stock Awards

  98   N/A  

(a)

 

Restricted Stock Units

  8   N/A  

(a)

 

Performance Stock Units

 

(c)

   N/A  

(a)

 

Total shares

  106       151